Cognizant's AI Rebound Meets a Guidance Haircut

A 51% ninety-day rally, a sharper AI narrative, and a lowered revenue guide collide in one print.

CTSH · Earnings Call · 2026-10-29

The set-up: a value stock in a victory lap

Cognizant came into this Q3 report as a beaten-down IT services name that had suddenly found a bid. The full price tape shows a 42% drawdown over 19 weeks before a 47% rebound in 15 weeks; the recent 90-day line is +50.9%, with a peak of $73.72 on October 22. By October 29, the stock was already 15.2% off that peak. That sequencing matters: management did not report into apathy — it reported into a sharp re-rating. The quarter itself was solid. Revenue was $5.7B, up 4.8% in constant currency; adjusted operating margin reached 16.3%, the highest in four years; adjusted EPS was $1.49, up 7%; and free cash flow was $925M. “Revenue grew 4.8% Y-o-Y in constant currency... adjusted operating margin increased year-over-year to 16.3%, the seventh consecutive quarter of year-over-year expansion.” — Ravi Kumar S, Chief Executive Officer · 2026-10-29 But the guide was cut.

Our full year guidance is now 4% to 4.4% growth in constant currency compared to 4% to 5.5% previously. This updated range is within the initial guidance we issued in February...
Jatin Dalal, Chief Financial Officer · 2026-10-29

The market's question is whether the AI story justifies the move, or whether the move front-ran the fundamentals.Total revenue was $5.5B in the latest filed quarter, up 4% year over year — respectable for IT services, but not a growth-stock number.

The AI story gets more precise — and more expensive to prove

The language has evolved. In prior quarters the company leaned on broad terms like AI Builder, swim lane, and agentic capital. This quarter the top company keywords are agentic systems, AI tailwind, institutional intelligence, secure AI, and deployment capacity. That is a shift from evangelism to architecture. The quantification is also better: 40% of revenue sits in service lines benefiting from AI tailwinds, growing at roughly 2 to 3x the rate of total organic services revenue; there are 8,500 AI engagements; more than 50% of software development is AI-assisted; and 95,000 certifications have been earned across frontier AI platforms. “service lines that are benefiting from AI tailwinds account for approximately 40% of our business and are growing at roughly 2 to 3x the rate of our total organic services revenue.” — Jatin Dalal, Chief Financial Officer · 2026-10-29 “we estimate more than 50% of our software development was AI-assisted and we have over 8,500 AI engagements.” — Ravi Kumar S, Chief Executive Officer · 2026-10-29 But note what has fallen out of the company's own keyword set: generic Agentic AI is now a decliner, and software development is a current decliner. Management is no longer selling agentic AI as a slogan; it is selling agentic systems at enterprise scale. That is more credible, but also more capital-intensive — the Gemini Frontier Capability Group, 18,000 dedicated associates, AI Nexus, and physical AI all require investment before they generate a revenue line. The bull case needs certifications and platforms to convert into billings, not just into slideware.

The guidance cut is not an AI problem — it is the old cyclical core

The cut came from health care and consumer-facing discretionary. “we are seeing the macro uncertainty weigh more on discretionary spending in the fourth quarter, particularly in health care and consumer-facing sectors.” — Ravi Kumar S, Chief Executive Officer · 2026-10-29 That is a reversal from prior confidence. In July 2025, Ravi downplayed the Medicaid/Medicare exposure:

our exposure to Medicaid and Medicare is not a lot... We have a lot of commercial health care.
Ravi Kumar Singisetti, Chief Executive Officer · 2025-07-30

In February 2026 he said: “Our health sciences business grew at six-plus percent, way higher than our company average.” — Ravi Kumar, Chief Executive Officer · 2026-02-04 Now health care did not grow, and Q4 is softer because of Medicaid and Medicare regulatory uncertainty. The keywords Medicaid and Medicare are gainers in the current trajectory — but as risk flags, not growth drivers. Similarly, consumer goods ranks second in the current keyword set, yet the transcript frames retail and consumer goods as pressured. That is the twist: the most prominent new keywords are headwinds, not boasts. Products and Resources remains under pressure from retail, consumer goods, travel/hospitality, and elevated oil prices; Belcan, manufacturing, logistics, and energy are the offsets.

Bookings and margins are the counter-case

The operational case is not broken. New bookings rank first in the company's keyword set, book-to-bill was 1.3x, the mix of new versus expanded business rose to 60%, trailing-twelve-month large-deal TCV increased 9%, and Cognizant signed three deals with TCV above $100M. Margin expansion has now run seven consecutive quarters, and Project Leap has been rescoped down: total cost is now $180M to $250M versus a prior $230M to $320M, with in-year savings of around $200M — the low end. That is a modest negative against the April message that the program would save “we're going to save $200 million to $300 million this year” — Ravi Kumar S, Chief Executive Officer · 2026-04-29. Still, the cash engine is real: Q3 free cash flow was $925M, year-to-date free cash flow $1.6B, and $2.3B has been returned to shareholders year-to-date. Operating margin was 15.9% in the latest filed quarter, up 0.4pp year over year. Valuation remains the crux: Price-to-net-income is 7.9x, price-to-free-cash-flow 7.3x, and price-to-revenue 0.8x. Cheap if growth holds; a value trap if guidance cuts continue. The balance sheet is less of a cushion than it once was: Effective net cash is -$509M, versus +$1.5B three years ago.

The India listing is the unspoken catalyst

The 90-day rally coincided with renewed India listing chatter. Jatin said the company is monitoring proposed regulatory updates that may become public in coming months and is prepared to complete its evaluation expeditiously once draft regulations are available. That is more advanced than the October 2025 language, when he called it an early-phase, long-term project. It could widen the investor base and narrow the valuation gap. But it is still an option, not a closed transaction. Meanwhile, the global AI data center trade has cooled: the theme showed 44 advancers versus 12 decliners over 360 days, but only 7 advancers versus 49 decliners over 90 days. Cognizant's rally is therefore not simply AI infrastructure beta. That makes the India listing and value re-rating more plausible as drivers — and makes the guidance cut more dangerous, because it undercuts the fundamental leg of the trade.

What actually changed

The AI narrative got more operational, and the revenue guide got worse. The stock's 51% ninety-day run means the market already gave management credit for the first; the cut takes some back. The next proof point is Q4 bookings conversion and whether health care stabilizes in 2027. Until then, Cognizant is a cheap stock with a credible margin story and a demand problem — not yet an AI growth story.